Last updated 2026-09-28
- Raised $9.4M Series B led by SIBF
- Raised $16.4M Undisclosed Round
- Raised $3M Series A led by eHealth Ventures, Aug 2024
Total raised
$35.5M
Last: Undisclosed Round 2024-08
Stage
Mature
Founded
2014
Headcount
30
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
DreaMed is an Israeli medical technology company that develops AI-based decision-support tools for diabetes management. Its core product, endo.digital, is a cloud-based SaaS platform that utilizes advanced AI and analytics to process patient data from continuous glucose monitoring, self-monitoring of blood glucose, and insulin pumps. The platform provides expert-level treatment recommendations for both Type 1 and Type 2 diabetes, aiming to improve living standards and lower treatment costs. DreaMed has received multiple FDA clearances for its technology.
Funding history · 5 rounds · $35.5M total
5 events/rounds · $35.5M Total Funding: $32.1M in Private Equity
Aug 2024
Jul 2016
★ Roman Abramovich★ Norma Investments Limited
Feb 2016
Grant
$3.4M
pitchbook.com
Date unknown
Date unknown
Undisclosed Round
$16.4M
quoted-total
Offices
Petah Tikva, Israel · HQ / main office
Q&A
- What is DreaMed's primary focus?
- DreaMed is an Israeli medical technology company that develops AI-based decision-support tools for diabetes management, specifically pioneering AI-driven solutions to transform patient data into personalized treatment recommendations.
- What is DreaMed's core product?
- DreaMed's core product is endo.digital, a cloud-based SaaS platform that uses advanced AI and analytics to process patient data from continuous glucose monitoring, self-monitoring of blood glucose, and insulin pumps. It provides expert-level treatment recommendations for both Type 1 and Type 2 diabetes.
- When was DreaMed founded and where is its headquarters?
- DreaMed was founded in March 2014 and is headquartered in Petah Tikva, Israel.
- What is DreaMed's total funding to date?
- DreaMed has raised a total of $35.5 million USD.
- When was DreaMed's most recent funding round and who participated?
- In August 2024, DreaMed raised an A Round of $3 million USD, with eHealth Ventures participating.
- Which investors participated in DreaMed's B Round?
- SIBF, OurCrowd, Medtronic, and eHealth Ventures participated in DreaMed's B Round.
- Has DreaMed received any regulatory clearances for its technology?
- Yes, DreaMed has received multiple FDA clearances for its technology.
Team · 4
Prof. Moshe Phillip
Founder · Chairman and Chief Scientist
Eran Atlas
Founder · CEO
Prof. Revital Nimri
Founder · Medical R&D Director
Ido Muller
Founder · Director of Data and Algorithms
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B SaaSB2C
Tags
health-techlife-sciencesmedical-devicedigital-healthaidiabetes-managementsaas
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | dreamed.ai/ |
|---|---|
| linkedin.com/company/5220173 |
Identifiers & details
| Founded | 2014-3 |
|---|---|
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 5 |
|---|
GitHub
| Top repos | uploader-stg-releases, node-data-tools, uploader-qa-releases, uploader-clinical-releases, uploader-releases |
|---|
Web history (Wayback)
| Domain | dreamed.ai |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515052520 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-03-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (2), people (2) |
| Registered address | קפלן אליעזר 14 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-15 | הקצאת מניות |
| 2026-04-12 | העברת מניות |
| 2026-03-10 | עדכון דירקטורים-הוספת דירקטור |
| 2026-03-10 | עדכון דירקטורים-הסרת דירקטור |